Cambridge Vision Technology Analysis
What is Cambridge Vision Technology?
First early warning system for Alzheimer's via optician visits
Location
New Haven, United States
Employees
1-10
Founded
2023
Product Features & Capabilities
- Retinal image analysis for Alzheimer's early warning
- Biomarker detection from retinal scans
- Ophthalmic, cardiovascular, and neurodegenerative disease screening
- Integration with local optician workflows
Use Cases
Screen for Alzheimer's during routine eye exams; Detect early signs of neurodegenerative diseases in optician visits; Enable early intervention for patients with retinal disease markers; Identify cardiovascular risk factors linked to Alzheimer's; Provide clinicians with actionable biomarkers for patient monitoring
Other Considerations
Scientifically validated diagnostic tests; Focus on early detection through optician visits; Partnerships with optician networks; Validated for ophthalmic, cardiovascular, and neurodegenerative diseases; Available in US, UK, and Switzerland
